Delivery Order SPE2DR25D3402-SPE2DR26F1WNM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,499.42 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL autoinjector on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $11,172.11 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on November 17, 2025, with completion expected by November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat various inflammatory and autoimmune conditions, including...
- The Defense Logistics Agency awarded a $23,185.33 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML AutoInjector on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and...
- The Defense Logistics Agency awarded a delivery order valued at $8,894.37 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on August 25, 2025, with completion scheduled for August 26, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a $26,229.86 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injectors, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on November 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a prescription biologic medication used to treat inflammatory...
- The Defense Logistics Agency awarded a $7,021.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML autoinjector on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic medication used to treat inflammatory conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing...
- The Defense Logistics Agency awarded a delivery order valued at $7,144.96 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on November 13, 2025, with final completion scheduled for November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant medication commonly prescribed for...
- The Defense Logistics Agency awarded a $21,972.38 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of TALTZ 80 mg/mL autoinjectors. This firm fixed-price delivery order, which is expected to be completed by August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,753.04 to AmerisourceBergen Drug Corp on June 4, 2025, for TALTZ 80 mg/ml autoinjector units. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of this pharmaceutical product through the federal procurement process. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 5, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,670.76 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL AutoInjector (2-pack) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TALTZ (ixekizumab) is a biologic immunosuppressant used in the treatment of autoimmune...
- SPE2DR25D3402Indefinite Delivery Contract
- SPE2DR25D3402-SPE2DR26F1WNMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,270.91 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. TALTZ (ixekizumab) is a biologic medication used in the treatment of autoimmune conditions, consistent with the specialized pharmaceutical portfolio that AmerisourceBergen maintains for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 11/17/25 |